DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014--
plc (NYSE:COV) today announced that its Board of Directors has declared
a quarterly cash dividend of $0.32 per ordinary share. The dividend is
payable on May 5, 2014, to shareholders of record on April 7, 2014.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien develops,
manufactures and sells a diverse range of industry-leading medical
device and supply products. With 2013 revenue of $10.2 billion, Covidien
has more than 38,000 employees worldwide in more than 70 countries, and
its products are sold in over 150 countries. Please visit www.covidien.com
to learn more about our business.
Peter Lucht, 508-452-4168
Coleman Lannum, CFA, 508-452-4343
Lisa Clemence, 508-452-4375
Todd Carpenter, 508-452-4363